» Articles » PMID: 39105977

Oral Health-related Quality of Life in Fanconi Anemia: a Cross-sectional Study

Abstract

Purpose: To evaluate the oral health-related quality of life (OHRQoL) of individuals diagnosed with Fanconi anemia (FA).

Methods: A cross-sectional study was conducted with FA patients from two Brazilian referral centers. Participants underwent a complete dental, periodontal, and oral mucosa examination, as well as assessment of resting salivary flow. The short version of the Oral Health Impact Profile (OHIP-14) questionnaire was administered. Descriptive and bivariate analyses were performed, followed by multivariate analysis to examine the impact of independent variables on OHRQoL.

Results: The study included 20 (57.1%) males and 15 (42.9%) females, with a mean age of 18.9 years. Oral leukoplakia (OL) was found in 18 individuals. The overall OHIP-14 score was 9.9 ± 10.5. Individuals aged ≥ 16 years had higher OHIP-14 scores, indicating worse OHRQoL for physical pain (p = 0.007), psychological discomfort (p = 0.001), physical disability (p = 0.03), psychological disability (p = 0.001), handicap (p = 0.004), and overall score (p = 0.007). Females reported more negative OHRQoL than males for physical pain (p = 0.02), psychological discomfort (p = 0.03), psychological disability (p = 0.009), and overall score (p = 0.02). Individuals with OL had an overall OHIP-14 score 1.83 times higher than those without OL (95% CI: 1.02-3.28; p = 0.04). Lower salivary flow correlated with higher overall OHIP-14 scores (95% CI: 0.14-0.84; p = 0.01).

Conclusion: This study represents the first attempt to evaluate OHRQoL in individuals with FA. The presence of OL and reduced salivary flow were identified as predictors of a negative impact on OHRQoL. It is imperative to integrate patients' quality of life in the clinical treatment protocols for the FA population.

References
1.
Kutler D, Singh B, Satagopan J, Batish S, Berwick M, Giampietro P . A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2002; 101(4):1249-56. DOI: 10.1182/blood-2002-07-2170. View

2.
Altintas B, Giri N, McReynolds L, Best A, Alter B . Genotype-phenotype and outcome associations in patients with Fanconi anemia: the National Cancer Institute cohort. Haematologica. 2022; 108(1):69-82. PMC: 9827153. DOI: 10.3324/haematol.2021.279981. View

3.
Zierhut H, Bartels D . Waiting for the next shoe to drop: the experience of parents of children with fanconi anemia. J Genet Couns. 2011; 21(1):45-58. DOI: 10.1007/s10897-011-9394-5. View

4.
Hutson S, Alter B . Experiences of siblings of patients with Fanconi anemia. Pediatr Blood Cancer. 2006; 48(1):72-9. DOI: 10.1002/pbc.20913. View

5.
Santana N, de Sena A, Rocha P, de Arruda J, Torres-Pereira C, Abreu L . Oral cancer and oral potentially malignant disorders in patients with Fanconi anemia - A systematic review. Oral Oncol. 2024; 150:106699. DOI: 10.1016/j.oraloncology.2024.106699. View